Successful multitarget therapy using prednisolone, mizoribine and tacrolimus for Henoch-Schönlein purpura nephritis in children.
Department of Dermatology, Nippon Medical School Hospital, Tokyo, Japan.
Susumu
S
Ichiyama
Department of Dermatology, Nippon Medical School Hospital, Tokyo, Japan.
Takemitsu
T
Matayoshi
Department of Nephrology, Nippon Medical School Hospital, Tokyo, Japan.
Tomohiro
T
Kaneko
Department of Analytic Human Pathology, Nippon Medical School Hospital, Tokyo, Japan.
Akira
A
Shimizu
Department of Dermatology, Nippon Medical School Hospital, Tokyo, Japan.
Shin-Ichi
SI
Osada
Division of Personalized Genetic Medicine, Nippon Medical School Hospital, Tokyo, Japan.
Atsushi
A
Watanabe
Department of Dermatology, Nippon Medical School Hospital, Tokyo, Japan.
Akiko
A
Kanzaki
Department of Gastroenterology, Nippon Medical School Hospital, Tokyo, Japan.
Keigo
K
Mitsui
Department of Nephrology, Nippon Medical School Hospital, Tokyo, Japan.
Shuichi
S
Tsuruoka
Department of Gastroenterology, Nippon Medical School Hospital, Tokyo, Japan.
Katsuhiko
K
Iwakiri
Department of Dermatology, Nippon Medical School Hospital, Tokyo, Japan.
Seiji
S
Kawana
Department of Dermatology, Nippon Medical School Hospital, Tokyo, Japan.
Hidehisa
H
Saeki
D000293:Adolescent; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D011695:IgA Vasculitis / Q000175:diagnosis* / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009393:Nephritis / Q000175:diagnosis* / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D011239:Prednisolone; D016559:Tacrolimus